Oticon Medical Announces FDA Premarket Approval For Neuro Cochlear Implant System To Treat Severe To Profound Sensorineural Hearing Loss
SOMERSET, N.J.–(BUSINESS WIRE)–Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or…